Important note: Information in this article was accurate in 1994. The state of the art may have changed since the publication date.
Changes of IgE production, splenic helper and suppressor T lymphocytes in mice infected with Paragonimus westermani.
Korean J Parasitol. 1993 Sep;31(3):231-8. Unique Identifier : AIDSLINE MED/94059903 Min DY; Ryu JS; Shin MH; Department of Parasitology, College of Medicine, Hanyang; University, Seoul, Korea.
Abstract:
Effects of Paragonims westermani infection were observed in mice on the change of serum IgE level, the number of peripheral eosinophils and the distribution of Thy 1.2+ (CD3), L3T4+ (CD4), and Lyt-2+ (CD8) splenic T lymphocytes without mitogen stimulation. BALB/c mice were infected with 20 metacercariae of P. westermani each. Total serum IgE increased at 3 weeks after the infection and reached a peak on week 4 and maintained high levels of IgE until the 23rd week. Peripheral eosinophil numbers increased at the second week and attained peak level on week 9. The frequency of L3T4+ (CD4) and Lyt-2+ (CD8) T lymphocytes decreased slightly until 4 weeks after the infection, but not significantly. Absolute number of L3T4+ and Lyt-2+ T lymphocytes, and the ratio of L3T4/Lyt-2 were not markedly changed over the period of observation. The frequency of Thy 1.2+ (CD3) T lymphocytes in the infected group slightly decreased until 4 weeks after the infection and showed significant reductions at the 2nd and 4th week of the infection (p < 0.05).
Keywords: Animal Antibodies, Helminth/BLOOD Crayfish/PARASITOLOGY CD4-CD8 Ratio Eosinophils IgE/*BLOOD Leukocyte Count Mice Mice, Inbred BALB C Paragonimiasis/*IMMUNOLOGY Paragonimus/*IMMUNOLOGY Spleen/CYTOLOGY Support, Non-U.S. Gov't *T-Lymphocyte Subsets *T-Lymphocytes, Helper-Inducer *T-Lymphocytes, Suppressor-Effector JOURNAL ARTICLE 940330
M9430969
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.